一个基于人口的时间序列分析在怀孕期间分配的阿片类药物激动剂治疗
Rose A Schmidt1,2,3, Karl Everett3, Amaya Perez-Brumer1
1Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Addiction (Abingdon, England)
|March 13, 2024
概括
自2018年以来,在安大略省怀孕期间的阿片类激素治疗 (OAT) 已经下降. 新指导方针和COVID-19大流行等干预措施对整体OAT率的影响最小.
科学领域:
- 生殖健康 生殖健康
- 成 药物 药物 药物 药物
- 公共卫生政策 公共卫生政策
背景情况:
- 孕期阿片类药物使用障碍是一个越来越令人担忧的问题.
- 怀孕期间有效的治疗选择至关重要.
- 人口层面的干预措施旨在影响治疗机会.
研究的目的:
- 评估在加拿大安大略省怀孕期间三项人口级干预措施对阿片类药激剂治疗 (OAT) 的影响.
- 分析孕妇中甲和布普伦诺芬使用的趋势.
- 为了评估表单变化,具体指导和COVID-19大流行对OAT患病率的影响.
主要方法:
- 基于人口的时间序列分析从2013年7月到2022年3月.
- 包括所有导致安大略省活产或死产的怀孕.
- 使用分发的甲和布普伦诺芬处方计算每月OAT患病率.
主要成果:
- 自2018年中期以来,怀孕期间OAT的总体发病率下降了.
- 甲暴露的怀孕率从2015年的0.46%下降到2022年的0.16%.
- 干预措施具有有限的统计学显著影响;在配方剂添加和指南释放/流行病发作后观察到轻微的布普伦诺芬变化.
结论:
- 自2018年以来,在安大略省怀孕期间的阿片类激素治疗一直在下降.
- 尽管政策和资金变化,但没有观察到对整体OAT率的重大影响.
- 可能需要进一步的研究来了解下降趋势并确定有效的策略.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
289
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
289
Opioid Analgesics: Morphine and Other Natural Cogeners
244
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
244
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Opioid Receptors: Overview
791
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
791
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K


